These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 25999730

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Akagi S, Nakamura K, Matsubara H, Kusano KF, Kataoka N, Oto T, Miyaji K, Miura A, Ogawa A, Yoshida M, Ueda-Ishibashi H, Yutani C, Ito H.
    Int J Cardiol; 2013 May 25; 165(3):499-505. PubMed ID: 21955608
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.
    McLaughlin VV, Palevsky HI.
    Clin Chest Med; 2013 Dec 25; 34(4):825-40. PubMed ID: 24267307
    [Abstract] [Full Text] [Related]

  • 5. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
    Rosenzweig EB, Kerstein D, Barst RJ.
    Circulation; 1999 Apr 13; 99(14):1858-65. PubMed ID: 10199883
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of continuous prostacyclin therapy in adults with pulmonary hypertension associated with congenital heart disease.
    Thomas IC, Glassner-Kolmin C, Gomberg-Maitland M.
    Int J Cardiol; 2013 Oct 09; 168(4):4117-21. PubMed ID: 23890862
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
    Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA.
    Ann Intern Med; 2000 Mar 21; 132(6):425-34. PubMed ID: 10733441
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV, Genthner DE, Panella MM, Rich S.
    N Engl J Med; 1998 Jan 29; 338(5):273-7. PubMed ID: 9445406
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension.
    Chin KM, Channick RN, de Lemos JA, Kim NH, Torres F, Rubin LJ.
    Chest; 2009 Jan 29; 135(1):130-136. PubMed ID: 18719056
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
    Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V.
    Am Heart J; 2014 Feb 29; 167(2):218-225.e1. PubMed ID: 24439983
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
    Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, Choussat R, Morin E, Thomas D.
    Am J Cardiol; 1998 Sep 15; 82(6):749-55. PubMed ID: 9761085
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and limitations of continuous intravenous epoprostenol therapy for idiopathic pulmonary arterial hypertension in Japanese children.
    Nakayama T, Shimada H, Takatsuki S, Hoshida H, Ishikita T, Matsuura H, Saji T.
    Circ J; 2007 Nov 15; 71(11):1785-90. PubMed ID: 17965503
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treprostinil for the treatment of pulmonary arterial hypertension.
    Torres F, Rubin LJ.
    Expert Rev Cardiovasc Ther; 2013 Jan 15; 11(1):13-25. PubMed ID: 23259441
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.